Controversy and conflict in the treatment of acute decompensated heart failure : nesiritide as evidence-based treatment
Acute decompensated heart failure poses a complex clinical challenge for the health care community. Evolving concepts of the pathophysiology and lack of consensus on appropriate outcome measures for drug approval underlie some of the current controversies about nesiritide. We outline the major controversies from the viewpoint that nesiritide should continue to be used judiciously by following its package insert recommendations and the Heart Failure Society of America's 2006 Comprehensive Heart Failure Practice Guidelines.
| Errataetall: |
CommentIn: Pharmacotherapy. 2007 May;27(5):626-32. - PMID 17461696 |
|---|---|
| Medienart: |
Artikel |
| Erscheinungsjahr: |
2007 |
|---|---|
| Erschienen: |
2007 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
|---|---|
| Enthalten in: |
Pharmacotherapy - 27(2007), 5 vom: 27. Mai, Seite 619-25 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Munger, Mark A [VerfasserIn] |
|---|
| Themen: |
114471-18-0 |
|---|
| Anmerkungen: |
Date Completed 26.06.2007 Date Revised 10.12.2019 published: Print CommentIn: Pharmacotherapy. 2007 May;27(5):626-32. - PMID 17461696 Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM169924483 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM169924483 | ||
| 003 | DE-627 | ||
| 005 | 20231223122407.0 | ||
| 007 | tu | ||
| 008 | 231223s2007 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0567.xml |
| 035 | |a (DE-627)NLM169924483 | ||
| 035 | |a (NLM)17461695 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Munger, Mark A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Controversy and conflict in the treatment of acute decompensated heart failure |b nesiritide as evidence-based treatment |
| 264 | 1 | |c 2007 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 26.06.2007 | ||
| 500 | |a Date Revised 10.12.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Pharmacotherapy. 2007 May;27(5):626-32. - PMID 17461696 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Acute decompensated heart failure poses a complex clinical challenge for the health care community. Evolving concepts of the pathophysiology and lack of consensus on appropriate outcome measures for drug approval underlie some of the current controversies about nesiritide. We outline the major controversies from the viewpoint that nesiritide should continue to be used judiciously by following its package insert recommendations and the Heart Failure Society of America's 2006 Comprehensive Heart Failure Practice Guidelines | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Natriuretic Agents |2 NLM | |
| 650 | 7 | |a Natriuretic Peptide, Brain |2 NLM | |
| 650 | 7 | |a 114471-18-0 |2 NLM | |
| 700 | 1 | |a Ng, Tien M H |e verfasserin |4 aut | |
| 700 | 1 | |a Van Tassell, Benjamin W |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacotherapy |d 1983 |g 27(2007), 5 vom: 27. Mai, Seite 619-25 |w (DE-627)NLM012960926 |x 1875-9114 |7 nnns |
| 773 | 1 | 8 | |g volume:27 |g year:2007 |g number:5 |g day:27 |g month:05 |g pages:619-25 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 27 |j 2007 |e 5 |b 27 |c 05 |h 619-25 | ||